01 1Cipla
01 1DARUNAVIR ETHANOLATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-02-20
Pay. Date : 2014-02-14
DMF Number : 23662
Submission : 2010-06-15
Status : Active
Type : II
20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DARUNAVIR ETHANOLATE, with a corresponding US DMF Number 23662.
Remarkably, this DMF maintains an Active status since its submission on June 15, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 20, 2014, and payment made on February 14, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
